Actively Recruiting
Pectopexy for Apical Prolapse Management
Led by Assiut University · Updated on 2024-05-10
10
Participants Needed
1
Research Sites
64 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study was designed to evaluate the efficacy of pectopexy for treatment of apical pelvic organ prolapse at follow up at 12 months. Investigator also evaluates complications, improvement of symptoms, quality-of-life outcomes and patient satisfaction with surgery. Assessment of restoration of normal pelvic anatomy and lower urinary tract symptoms using transperineal ultrasound
CONDITIONS
Official Title
Pectopexy for Apical Prolapse Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Apical prolapse Stage 2-4 according to POP-Q system
- Uterine preservation or after hysterectomy
- Age greater than 18 years old
- Sexually active or not
You will not qualify if you...
- Pregnancy or up to 6 months postpartum
- Current urinary tract infection confirmed by urine analysis or culture
- Patient unfit for surgery
- Previous suspension operations
- Uncontrolled diabetic patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Women Health Hospital
Asyut, Egypt
Actively Recruiting
Research Team
M
Mohamed Fekry, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here